MedTrace Logo

External ValidatIon Trial of ASTER Trial

NCT01332240 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 255

Last updated 2011-10-19

No results posted yet for this study

Summary

As the use of endoscopic ultrasonography for mediastinal diagnosis and/or staging is widely spread in Belgium, the investigators aimed to determine the number of mediastinoscopies needed to detect one additional mediastinal lymph node invasion during routine clinical practice in the staging of potentially resectable clinical stage III non-small cell lung cancer.

Conditions

  • Stage III Lung Cancer

Interventions

PROCEDURE

Endoscopic ultrasonography

in order to stage the mediastinum

Sponsors & Collaborators

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Principal Investigators

  • Christophe Dooms · Universitaire Ziekenhuizen KU Leuven

  • Kurt Tournoy · University Hospital Ghent Belgium

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2013-04-30
Completion
2013-07-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01332240 on ClinicalTrials.gov